Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00597116 · BASELINE

Baseline characteristics

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma · Source last updated 2016-10-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      13
    2. group Id
      BG001
      value
      10
    3. group Id
      BG002
      value
      23
    units
    Participants
groups
  1. description
    Vandetanib 300 mg/day oral
    id
    BG000
    title
    Vandetanib
  2. description
    Vinorelbine 30 mg/m2 iv, administrated weekly
    id
    BG001
    title
    Vinorelbine
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          54
          upper Limit
          77
          value
          67
        2. group Id
          BG001
          lower Limit
          27
          upper Limit
          76
          value
          64
        3. group Id
          BG002
          lower Limit
          27
          upper Limit
          77
          value
          65.5
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          12
        2. group Id
          BG001
          value
          10
        3. group Id
          BG002
          value
          22
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      13
    2. group Id
      BG001
      value
      10
    3. group Id
      BG002
      value
      23
    units
    Participants
groups
  1. description
    Vandetanib 300 mg/day oral
    id
    BG000
    title
    Vandetanib
  2. description
    Vinorelbine 30 mg/m2 iv, administrated weekly
    id
    BG001
    title
    Vinorelbine
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          54
          upper Limit
          77
          value
          67
        2. group Id
          BG001
          lower Limit
          27
          upper Limit
          76
          value
          64
        3. group Id
          BG002
          lower Limit
          27
          upper Limit
          77
          value
          65.5
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          1
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          12
        2. group Id
          BG001
          value
          10
        3. group Id
          BG002
          value
          22
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice